Advocacy

We believe that all melanoma patients have the right to the best evidence based treatments available, to seek a second opinion and to have confidence in their healthcare team.

We have an ongoing commitment to work with government, clinicians and industry to increase awareness, highlight the need for further research, advocate for equitable access to new and innovative treatments and contribute to policy development to improve the lives and outcomes of all Australians affected by melanoma.

Increasingly, people affected by cancer and the broader community are seeking to be active participants in decision making about their health and as an organisation that represents those affected by melanoma, MPA is interested in actively engaging with consumers around a shared focus and vision.